Regulatory Snapshot for Pharmaceutical Trade Naming Around the World

Proprietary naming regulations can differ between regulatory bodies around the world. Here we've highlighted a few important regulatory considerations for each government agency. Since regulatory guidance is constantly evolving, please verify that the information is current before proceeding with...

Leaderboard Branding Expands with Strategic Hire, Hermann Spicker

With strong industry relationships, Spicker further amplifies Leaderboard’s branding and naming expertise in the biopharma space.

Trademark Trends 2023: Is Your Organization Prepared For The Future?

January, the time of year when organizations are keen to offer up their Year in Review (2022) and hypothesize on developments we could see in the future. In this case, we’re not talking about the latest TikTok trend, but we have our eye on trademark trends. Trademarks might not be top of mind for...

Leaderboard Branding Hires Former FDA DMEPA Evaluator

Leaderboard Branding Adds to Expert Drug Safety Division With Influential Hire: Former FDA DMEPA Evaluator

Leaderboard's Team Take

We asked a few Leaderboarders for their take on the Facebook rebrand. Here is what they had to say.

Globally Recognized Brand Naming and Brand Strategy Expert Joins Leaderboard Branding

The Leaderboard Branding team is excited to welcome expert naming and branding strategist, Brittany Scott. Ms. Scott joins the firm as the Director of Brand Innovation. In this global role, Brittany will promote growth, inspire creativity, and develop new tools to define Leaderboard's market...

Our Team Is Growing!

Leaderboard is excited to welcome a new member of the Market Research team, Kat Morris. As a new associate, Kat brings a deep level of knowledge in the research space.

Key Insights on Developing Investigational Drug Container Labels

FDA's Virtual Meeting on Investigational Drug Container Labels

Fingerpaint Announces Strategic Investment in Leaderboard Branding

Supports Fingerpaint’s Continued Expansion of its World-Class Healthcare Commercialization Capabilities

Research: Perspective not Directive

Identify Opportunity. Mitigate Risk.